vs
太平洋生物科学（ASMB）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
RIVERVIEW BANCORP INC的季度营收约是太平洋生物科学的1.3倍（$14.0M vs $10.8M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -85.2%，领先95.0%），太平洋生物科学同比增速更快（57.6% vs 10.4%），RIVERVIEW BANCORP INC自由现金流更多（$-736.0K vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
ASMB vs RVSB — 直观对比
营收规模更大
RVSB
是对方的1.3倍
$10.8M
营收增速更快
ASMB
高出47.2%
10.4%
净利率更高
RVSB
高出95.0%
-85.2%
自由现金流更多
RVSB
多$14.4M
$-15.2M
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $14.0M |
| 净利润 | $-9.2M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | 12.4% |
| 净利率 | -85.2% | 9.8% |
| 营收同比 | 57.6% | 10.4% |
| 净利润同比 | 4.3% | 11.8% |
| 每股收益（稀释后） | $-0.72 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBRVSB
| Q4 25 | — | $14.0M | ||
| Q3 25 | $10.8M | $13.6M | ||
| Q2 25 | $9.6M | $13.3M | ||
| Q1 25 | $9.4M | $12.9M | ||
| Q4 24 | $7.4M | $12.7M | ||
| Q3 24 | $6.8M | $12.8M | ||
| Q2 24 | $8.5M | $12.2M | ||
| Q1 24 | $5.8M | $9.0M |
净利润ASMBRVSB
| Q4 25 | — | $1.4M | ||
| Q3 25 | $-9.2M | $1.1M | ||
| Q2 25 | $-10.2M | $1.2M | ||
| Q1 25 | $-8.8M | $1.1M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | $-9.6M | $1.6M | ||
| Q2 24 | $-11.2M | $966.0K | ||
| Q1 24 | $-9.1M | $-3.0M |
营业利润率ASMBRVSB
| Q4 25 | — | 12.4% | ||
| Q3 25 | -100.9% | 10.2% | ||
| Q2 25 | -115.2% | 11.7% | ||
| Q1 25 | -105.5% | 11.3% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | -160.1% | 15.5% | ||
| Q2 24 | -143.0% | 10.0% | ||
| Q1 24 | -185.5% | -47.5% |
净利率ASMBRVSB
| Q4 25 | — | 9.8% | ||
| Q3 25 | -85.2% | 8.1% | ||
| Q2 25 | -105.9% | 9.2% | ||
| Q1 25 | -93.6% | 8.9% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | -140.4% | 12.2% | ||
| Q2 24 | -130.7% | 7.9% | ||
| Q1 24 | -156.9% | -34.7% |
每股收益（稀释后）ASMBRVSB
| Q4 25 | — | $0.07 | ||
| Q3 25 | $-0.72 | $0.05 | ||
| Q2 25 | $-1.33 | $0.06 | ||
| Q1 25 | $-1.17 | $0.05 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | $-1.51 | $0.07 | ||
| Q2 24 | $-1.98 | $0.05 | ||
| Q1 24 | $-1.66 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $164.2M |
| 总资产 | $240.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBRVSB
| Q4 25 | — | $28.6M | ||
| Q3 25 | $22.5M | $32.8M | ||
| Q2 25 | $24.0M | $34.2M | ||
| Q1 25 | $23.4M | $29.4M | ||
| Q4 24 | $38.3M | $25.3M | ||
| Q3 24 | $28.5M | $31.0M | ||
| Q2 24 | $19.2M | $27.8M | ||
| Q1 24 | $18.7M | $23.6M |
股东权益ASMBRVSB
| Q4 25 | — | $164.2M | ||
| Q3 25 | $182.7M | $163.5M | ||
| Q2 25 | $18.1M | $162.0M | ||
| Q1 25 | $27.1M | $160.0M | ||
| Q4 24 | $33.4M | $158.3M | ||
| Q3 24 | $26.0M | $160.8M | ||
| Q2 24 | $34.7M | $155.9M | ||
| Q1 24 | $32.6M | $155.6M |
总资产ASMBRVSB
| Q4 25 | — | $1.5B | ||
| Q3 25 | $240.0M | $1.5B | ||
| Q2 25 | $80.8M | $1.5B | ||
| Q1 25 | $99.0M | $1.5B | ||
| Q4 24 | $119.2M | $1.5B | ||
| Q3 24 | $100.3M | $1.5B | ||
| Q2 24 | $115.3M | $1.5B | ||
| Q1 24 | $119.9M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $-736.0K |
| 自由现金流率自由现金流/营收 | -140.7% | -5.2% |
| 资本支出强度资本支出/营收 | 0.4% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | — | $20.4M |
8季度趋势，按日历期对齐
经营现金流ASMBRVSB
| Q4 25 | — | $-506.0K | ||
| Q3 25 | $-15.1M | $16.8M | ||
| Q2 25 | $-16.8M | $-697.0K | ||
| Q1 25 | $-23.4M | $8.3M | ||
| Q4 24 | $-51.1M | $2.2M | ||
| Q3 24 | $-15.2M | $764.0K | ||
| Q2 24 | $-17.1M | $5.4M | ||
| Q1 24 | $-18.4M | $12.8M |
自由现金流ASMBRVSB
| Q4 25 | — | $-736.0K | ||
| Q3 25 | $-15.2M | $16.4M | ||
| Q2 25 | — | $-773.0K | ||
| Q1 25 | — | $5.6M | ||
| Q4 24 | $-51.1M | $1.9M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | $-17.1M | $5.3M | ||
| Q1 24 | $-18.4M | $7.1M |
自由现金流率ASMBRVSB
| Q4 25 | — | -5.2% | ||
| Q3 25 | -140.7% | 120.1% | ||
| Q2 25 | — | -5.8% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | -695.2% | 15.0% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | -200.6% | 43.7% | ||
| Q1 24 | -317.7% | 79.0% |
资本支出强度ASMBRVSB
| Q4 25 | — | 1.6% | ||
| Q3 25 | 0.4% | 2.9% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.0% | 21.0% | ||
| Q4 24 | 0.4% | 2.4% | ||
| Q3 24 | 0.0% | 17.3% | ||
| Q2 24 | 0.2% | 0.9% | ||
| Q1 24 | 0.2% | 62.0% |
现金转化率ASMBRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
